Literature DB >> 12477750

RUNX 3, apoptosis 0: a new gastric tumour suppressor.

S F Moss1.   

Abstract

Entities:  

Year:  2003        PMID： 12477750      PMCID： PMC1773493          DOI： 10.1136/gut.52.1.12

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

Review 1.  Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.

Authors:  M Weinstein; X Yang; C Deng
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

2.  Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.

Authors:  H Ijichi; T Ikenoue; N Kato; Y Mitsuno; G Togo; J Kato; F Kanai; Y Shiratori; M Omata
Journal:  Biochem Biophys Res Commun       Date:  2001-11-30       Impact factor: 3.575

3.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582
  3 in total
  2 in total

1.  H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis.

Authors:  Masayuki Suzuki; Hidekazu Suzuki; Yuriko Minegishi; Kosei Ito; Toshihiro Nishizawa; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

Review 2.  Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.

Authors:  Marta E Alarcón-Riquelme
Journal:  Arthritis Res Ther       Date:  2004-06-21       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.